Mark Basil Swindells
Corporate Officer/Principal bei Exscientia AI Ltd.
Profil
Mark Basil Swindells is currently the Chief Strategy Officer at Exscientia AI Ltd.
He previously held the same position at Exscientia Plc.
Aktive Positionen von Mark Basil Swindells
| Unternehmen | Position | Beginn |
|---|---|---|
Exscientia AI Ltd.
 Exscientia AI Ltd. Pharmaceuticals: GenericHealth Technology Exscientia AI Ltd. is an artificial intelligence (AI) driven pharmatech company, which develops bi-specific small molecule immuno-oncology therapeutics. The firm offers phenotypic drug design and selective single target molecules. The company was founded by Andrew Lee Hopkins in July 2012 and is headquartered in Oxford, the United Kingdom. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Mark Basil Swindells
| Unternehmen | Position | Ende |
|---|---|---|
| EXSCIENTIA PLC | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| EXSCIENTIA PLC | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Exscientia AI Ltd.
Exscientia AI Ltd. Pharmaceuticals: GenericHealth Technology Exscientia AI Ltd. is an artificial intelligence (AI) driven pharmatech company, which develops bi-specific small molecule immuno-oncology therapeutics. The firm offers phenotypic drug design and selective single target molecules. The company was founded by Andrew Lee Hopkins in July 2012 and is headquartered in Oxford, the United Kingdom. | Health Technology |